CCI
NBIX icon

Columbus Circle Investors’s Neurocrine Biosciences NBIX Stock Holding History

Columbus Circle Investors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-342,465
Closed -$24.5M – 171
2018
Q4 		$24.5M Sell
342,465
-73,925
-18% -$7.08M 0.69% 62
2018
Q3 		$51.2M Sell
416,390
-14,108
-3% -$1.6M 1.02% 27
2018
Q2 		$42.3M Buy
430,498
+54,172
+14% +$4.85M 0.87% 35
2018
Q1 		$31.2M Buy
376,326
+57,520
+18% +$4.86M 0.63% 64
2017
Q4 		$24.7M Buy
+318,806
New +$21.7M 0.47% 85
2017
Q2 		– Sell
-207,699
Closed -$8.99M – 274
2017
Q1 		$8.99M Buy
207,699
+51,872
+33% +$2.22M 0.13% 155
2016
Q4 		$6.03M Sell
155,827
-63,935
-29% -$2.89M 0.08% 178
2016
Q3 		$11.1M Buy
219,762
+127,962
+139% +$6.37M 0.12% 146
2016
Q2 		$4.17M Sell
91,800
-89,184
-49% -$4.11M 0.04% 202
2016
Q1 		$7.16M Sell
180,984
-459,433
-72% -$18.2M 0.06% 200
2015
Q4 		$36.2M Buy
640,417
+177,362
+38% +$9.01M 0.29% 83
2015
Q3 		$18.4M Buy
+463,055
New +$22.4M 0.15% 135
2015
Q1 		– Sell
-565,843
Closed -$12.6M – 315
2014
Q4 		$12.6M Buy
565,843
+543,066
+2,384% +$10.3M 0.09% 188
2014
Q3 		$357K Sell
22,777
-94,363
-81% -$1.41M ﹤0.01% 255
2014
Q2 		$1.74M Buy
+117,140
New +$1.65M 0.01% 253

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbus Circle Investors's NBIX Position: Q1 2019 in Review

Columbus Circle Investors sold out of Neurocrine Biosciences (NBIX) in Q1 2019, closing a stake of 342,465 shares — an estimated $24.5M sold.

Columbus Circle Investors first reported a position in NBIX in Q2 2014 and held it in 15 quarters. The position peaked at $51.2M in Q3 2018. 325 funds tracked by Wall St. Rank hold NBIX as of Q1 2019.

  • Columbus Circle Investors reported no remaining Neurocrine Biosciences position as of Q1 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 342,465 Neurocrine Biosciences shares in Q1 2019, an estimated $24.5M.
  • Columbus Circle Investors first reported a position in Neurocrine Biosciences in Q2 2014 and held it in 15 quarters.
  • Columbus Circle Investors's Neurocrine Biosciences position peaked at $51.2M in Q3 2018.
  • 325 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2019.

Based on Columbus Circle Investors's 13F filing for Q1 2019, filed 22 Apr 2019.